Cargando…

The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca(2+) channels

The present study investigates the effect of commonly used negative and positive allosteric modulators of the calcium-sensing receptor (CaSR) on vascular reactivity. In wire myography studies, increasing [Ca(2+)](o) from 1 mM to 6 mM induced concentration-dependent relaxations of methoxamine-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Greenberg, Harry Z.E., Jahan, Kazi S., Shi, Jian, Vanessa Ho, W.-S., Albert, Anthony P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Cardiovascular Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127511/ https://www.ncbi.nlm.nih.gov/pubmed/27725162 http://dx.doi.org/10.1016/j.ejphar.2016.10.008

Ejemplares similares

Synthesis of the calcilytic ligand NPS 2143
por: Johansson, Henrik, et al.
Publicado: (2013)

The Calcilytic Drug Calhex-231 Ameliorates Vascular Hyporesponsiveness in Traumatic Hemorrhagic Shock by Inhibiting Oxidative Stress and miR-208a-Mediated Mitochondrial Fission
por: Lei, Yan, et al.
Publicado: (2020)

Calcilytic NPS2143 promotes proliferation and inhibits apoptosis of spontaneously hypertensive rat vascular smooth muscle cells via activation of the renin-angiotensin system
por: Zhao, Yongli, et al.
Publicado: (2020)

Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143—Further Implications for Alzheimer's Therapy
por: Chiarini, Anna, et al.
Publicado: (2017)

The Calcilytic Agent NPS 2143 Rectifies Hypocalcemia in a Mouse Model With an Activating Calcium-Sensing Receptor (CaSR) Mutation: Relevance to Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Hannan, Fadil M., et al.
Publicado: (2015)

CaSR Antagonist (Calcilytic) NPS 2143 Hinders the Release of Neuroinflammatory IL-6, Soluble ICAM-1, RANTES, and MCP-2 from Aβ-Exposed Human Cortical Astrocytes
por: Chiarini, Anna, et al.
Publicado: (2020)

Calcilytic NPS 2143 Reduces Amyloid Secretion and Increases sAβPPα Release from PSEN1 Mutant iPSC-Derived Neurons
por: Lo Giudice, Maria, et al.
Publicado: (2019)

Amino Alcohol- (NPS-2143) and Quinazolinone-Derived Calcilytics (ATF936 and AXT914) Differentially Mitigate Excessive Signalling of Calcium-Sensing Receptor Mutants Causing Bartter Syndrome Type 5 and Autosomal Dominant Hypocalcemia
por: Letz, Saskia, et al.
Publicado: (2014)

MARCKS mediates vascular contractility through regulating interactions between voltage-gated Ca(2+) channels and PIP(2)
por: Jahan, Kazi S., et al.
Publicado: (2020)

Calhex231 ameliorates myocardial fibrosis post myocardial infarction in rats through the autophagy‐NLRP3 inflammasome pathway in macrophages
por: Liu, Wenxiu, et al.
Publicado: (2020)

The CaSR Modulator NPS-2143 Reduced UV-Induced DNA Damage in Skh:hr1 Hairless Mice but Minimally Inhibited Skin Tumours
por: Yang, Chen, et al.
Publicado: (2023)

Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013)

Inhibition of Excessive Cell Proliferation by Calcilytics in Idiopathic Pulmonary Arterial Hypertension
por: Yamamura, Aya, et al.
Publicado: (2015)

Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
por: Arenas, Maria Dolores, et al.
Publicado: (2020)

Localization of the Activation Gate of a Voltage-gated Ca(2+) Channel
por: Xie, Cheng, et al.
Publicado: (2005)

Calcium-Sensing Receptor Antagonist NPS 2143 Restores Amyloid Precursor Protein Physiological Non-Amyloidogenic Processing in Aβ-Exposed Adult Human Astrocytes
por: Chiarini, Anna, et al.
Publicado: (2017)

Gα(11) mutation in mice causes hypocalcemia rectifiable by calcilytic therapy
por: Gorvin, Caroline M., et al.
Publicado: (2017)

Expression and function of voltage gated proton channels (H(v)1) in MDA-MB-231 cells
por: Bare, Dan J., et al.
Publicado: (2020)

Mutant Mice With Calcium-Sensing Receptor Activation Have Hyperglycemia That Is Rectified by Calcilytic Therapy
por: Babinsky, Valerie N., et al.
Publicado: (2017)

Correction: Expression and function of voltage gated proton channels (H(v)1) in MDA-MB-231 cells
Publicado: (2020)

Parathyroidectomy Versus Calcimimetic: The Lower the PTH the Better?
por: Evenepoel, Pieter, et al.
Publicado: (2022)

Calmodulin and Ca(2+) control of voltage gated Na(+) channels
por: Gabelli, Sandra B, et al.
Publicado: (2015)

Calcimimetic acts on enteric neuronal CaSR to reverse cholera toxin-induced intestinal electrolyte secretion
por: Tang, Lieqi, et al.
Publicado: (2018)

Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused by biased allosteric CaSR autoantibodies
por: Makita, Noriko, et al.
Publicado: (2022)

Molecular insights into the gating mechanisms of voltage-gated calcium channel Ca(V)2.3
por: Gao, Yiwei, et al.
Publicado: (2023)

Cnidarian Toxins Acting on Voltage-Gated Ion Channels
por: Messerli, Shanta M., et al.
Publicado: (2006)

Functional role of voltage gated Ca(2+) channels in heart automaticity
por: Mesirca, Pietro, et al.
Publicado: (2015)

Ca(2+)-dependent modulation of voltage-gated myocyte sodium channels
por: Salvage, Samantha C., et al.
Publicado: (2021)

2143. in-vitro activity of Bacteriophages against Methicillin-Resistant Staphylococcus aureus Biofilms
por: Parmar, Krupa, et al.
Publicado: (2023)

Clinical Outcomes in Secondary Hyperparathyroidism and the Potential Role of Calcimimetics
por: Cunningham, John, et al.
Publicado: (2008)

Secondary Hyperparathyroidism Disease Stabilization Following Calcimimetic Therapy
por: Frazão, João, et al.
Publicado: (2008)

Calcimimetics in CKD—results from recent clinical studies
por: Schlieper, Georg, et al.
Publicado: (2008)

Tetraspanin-13 modulates voltage-gated Ca(V)2.2 Ca(2+) channels
por: Mallmann, Robert T., et al.
Publicado: (2013)

Functional Architecture of the Inner Pore of a Voltage-gated Ca(2+) Channel
por: Zhen, Xiao-guang, et al.
Publicado: (2005)

Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief
por: Lee, Seungkyu
Publicado: (2013)

Structural basis for Ca(2+) selectivity of a voltage-gated calcium channel
por: Tang, Lin, et al.
Publicado: (2013)

The voltage gated Ca(2+)-channel Ca(v)3.2 and therapeutic responses in breast cancer
por: Pera, Elena, et al.
Publicado: (2016)

Graded Ca(2+)/calmodulin-dependent coupling of voltage-gated Ca(V)1.2 channels
por: Dixon, Rose E, et al.
Publicado: (2015)

Allosteric Voltage Gating of Potassium Channels II: Mslo Channel Gating Charge Movement in the Absence of Ca(2+)
por: Horrigan, Frank T., et al.
Publicado: (1999)

Solution Structure of Kurtoxin: A Gating Modifier Selective for Cav3 Voltage-Gated Ca(2+) Channels
por: Lee, Chul Won, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_i44orqeveptgi1f7coqc4hksgj